Insulin Resistance: The Metabolic Pattern Behind Most Chronic Disease in India

Grinto Davy
1 day ago
7 min read

Rajan is 36. He works as a accountant in Thrissur. His fasting blood sugar is 94 mg/dL, well within normal. Her HbA1c is 5.4, not diabetic, not even prediabetic by any standard cutoff.

He has gained about 12 kilograms over five years, almost entirely around her abdomen. He craves something sweet every afternoon, especially around 3 PM.He wakes up most mornings already tired. He has been to two nutritionists. Both gave him meal plans. Neither worked beyond the first six weeks. Beacuse all focused in weightloss

Every test says he is fine. He does not feel fine.

What Rajan has and what his tests are not showing is insulin resistance. It is the most common and most underdiagnosed metabolic condition in India. It is the engine driving obesity, Type 2 diabetes, PCOD, fatty liver, high triglycerides, and cardiometabolic risk. And it can be present for years, sometimes decades, before any standard blood test flags it.

What People Search — and Why

"why is my belly fat not reducing despite dieting"

"fasting sugar normal but always tired and craving sugar"

"doctor says I'm fine but I keep gaining weight"

"what is insulin resistance and how to fix it"

"PCOD and weight gain — is it hormonal or something else"

These are the searches of people whose bodies are signalling something that standard panels are not catching yet. The frustration in those searches is real. And it is usually insulin resistance that sits at the centre of it.

What Insulin Resistance Actually Is

Insulin is a hormone produced by the pancreas. Its job is straightforward: it acts as a key that unlocks cells, allowing glucose from your blood to enter and be used as energy.

Insulin resistance means the locks have stopped responding to the key. Cells in muscle, liver, and fat tissue stop responding normally to insulin's signal. The pancreas compensates by producing more and more insulin trying to force the door open. For a while, it works. Blood glucose stays relatively normal. But fasting insulin is rising, and the body is working far harder than it should.

Eventually, one of two things happens. The pancreas cannot keep up, and blood glucose begins to rise, entering the prediabetes and then diabetes spectrum. Or the chronically elevated insulin itself causes its own cascade of damage: fat accumulation, particularly visceral fat; triglyceride elevation; HDL suppression; hormonal disruption in women; inflammatory signalling; and progressive metabolic dysfunction.

This is why insulin resistance matters enormously even when blood sugar is completely normal. The damage is not in the glucose — it is in the insulin.

Why India Has a Particularly Serious Insulin Resistance Problem

Evidence: A 2022 meta-analysis in The Lancet Diabetes & Endocrinology (Anjana et al., epidemiology of insulin resistance in South Asian populations) found that South Asians develop insulin resistance at lower BMI thresholds than Western populations — meaning an Indian person with a 'healthy' BMI may already have significant metabolic dysfunction.

The visceral fat distribution typical in South Asians compounds this risk substantially. Standard BMI and fasting glucose thresholds miss a large portion of insulin resistance in the Indian population.

This has a direct clinical implication: the diagnostic tools were calibrated on different bodies. ESCASO uses functional metabolic ranges and additional markers — fasting insulin, HOMA-IR, triglyceride-to-HDL ratio — specifically because the standard panel is insufficient for the Indian metabolic profile.

How to Recognise Insulin Resistance — The Pattern, Not Just the Test

Standard labs will not show insulin resistance until it is quite advanced. What shows it earlier is a pattern of symptoms and lifestyle signals that, taken together, paint a clear picture.

Central weight gain

Fat that accumulates predominantly around the abdomen and waist, disproportionate to overall body size. This is visceral fat — the metabolically active fat stored around internal organs that directly worsens insulin signalling.

Post-meal fatigue

Feeling significantly tired or foggy 30–60 minutes after eating, particularly after carbohydrate-heavy meals. This reflects exaggerated insulin release followed by relative glucose instability.

Afternoon energy crashes and sugar cravings

The classic 3 PM slump and craving for something sweet. This is the body attempting to counteract the glucose dip that follows a compensatory insulin spike.

Difficulty losing weight despite caloric restriction

Chronically elevated insulin actively inhibits fat breakdown (lipolysis). Calorie reduction does not override elevated insulin. This is why calorie-focused programmes fail in people with significant insulin resistance.

Skin changes — acanthosis nigricans

Darkened, thickened skin at the neck, underarms, and groin. This is a direct clinical marker of hyperinsulinemia and is commonly present in people with insulin resistance, including children.

Elevated fasting triglycerides with low HDL

One of the clearest metabolic markers. Insulin resistance impairs triglyceride clearance and suppresses HDL production. A triglyceride-to-HDL ratio above 3.0 in Indians is a reliable surrogate marker for insulin resistance even when fasting glucose is normal.

In women — menstrual irregularity and fertility difficulty

Insulin resistance drives ovarian hyperandrogenism in PCOD. This is not primarily a hormonal disorder. It is, at root, a metabolic one.

What HOMA-IR Is and Why It Matters

HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) is a calculated index derived from fasting insulin and fasting glucose. It is the most practical non-invasive measure of insulin resistance available in routine clinical settings.

Standard labs in India rarely include fasting insulin in routine panels. Most doctors do not order it unless the patient is already diabetic. This is the diagnostic gap that allows insulin resistance to progress unchecked for years.

ESCASO routinely includes fasting insulin and HOMA-IR assessment in metabolic workups, interpreted through functional optimal ranges, not just the wide reference ranges printed by laboratories. A fasting insulin above 8 μIU/mL in a fasting state, even with normal fasting glucose, is a clinically significant finding. A HOMA-IR above 2.0 in Indian populations warrants intervention.

The Conditions Insulin Resistance Drives

Type 2 Diabetes — insulin resistance is the precursor in over 90% of cases. Addressing insulin resistance reverses the direction of the progression continuum
PCOD/PCOS — elevated insulin directly stimulates the ovaries to produce androgens. Insulin resistance correction is not an add-on to PCOD treatment. In most cases, it is the treatment
Non-Alcoholic Fatty Liver Disease (NAFLD/MASLD) — elevated insulin drives de novo lipogenesis. Fatty liver responds to the same interventions that correct insulin resistance
Dyslipidemia and Cardiometabolic Risk — elevated triglycerides, low HDL, and small dense LDL particles are metabolic consequences of insulin resistance, not primarily dietary ones
Hypertension — insulin resistance contributes to sodium retention and vascular inflammation — both drive elevated blood pressure

→ Read about ESCASO's approach to metabolic disease: /about

What It Actually Takes to Correct Insulin Resistance

This is where most guidance fails. The standard advice like eat less, move more, cut sugar are identifies approximately the right direction but misses almost everything that matters in practice.

Evidence 1: A 2020 Cochrane systematic review and meta-analysis on low-glycaemic-index and low-carbohydrate dietary patterns found consistent and clinically significant improvements in fasting insulin, HOMA-IR, and HbA1c — durable at 12 months. The key variable was not calorie restriction. It was dietary pattern quality and carbohydrate source.

Evidence 2: A 2017 meta-analysis in Diabetes Care (Colberg et al.) confirmed that structured physical activity — particularly resistance and combined modalities — improved insulin sensitivity independently of weight loss. Movement corrects insulin resistance through mechanisms that have nothing to do with calories burned.

Food pattern correction

Not calorie counting. The GDDiET® food framework identifies carbohydrate quality, meal timing patterns, fat composition, and protein adequacy — framed as decision rules that work within Indian food culture and family meals. There is no meal plan. There are principles that become habits.

Metabolic physiotherapy

Structured movement calibrated to individual capacity, including for people who cannot do conventional exercise due to joint pain, obesity-related fatigue, or mobility limitations. Movement is medicine for insulin resistance. But it must be the right movement for the right body.

Sleep and stress pattern work

Cortisol is an insulin antagonist. Chronic sleep disruption and elevated cortisol maintain insulin resistance independently of diet. ESCASO includes sleep architecture and stress physiology in the clinical assessment and the correction protocol.

The review loop

Metabolic correction is not linear. ESCASO's structured review cycles track marker progression, identify stalled patterns, and adjust the approach. This is what separates clinical management from a programme you follow and hope for the best.

→ Learn how GDDiET® addresses insulin resistance at root level: /gddiet-protocol-metabolic-health-india

→ Book a metabolic assessment at ESCASO: /consultations-services

If You Recognise Your Pattern in This Page

Insulin resistance is correctable. Not permanently - it requires sustained lifestyle architecture - but significantly and measurably so in most people, within weeks of consistent application.

The first step is understanding your own pattern. Not guessing. Not following generic advice. Actually mapping what is happening in your body with the right markers and the right clinical lens.

If your blood tests look normal but your body is telling you something different, you are probably right.

→ Start with a metabolic clarity consultation at ESCASO: /consultations-services

→ Understand the GDDiET® protocol that addresses insulin resistance: /gddiet-protocol-metabolic-health-india

→ Read about how ESCASO works differently: /how-we-work

Frequently Asked Questions

Q: What is the difference between insulin resistance and diabetes?

A: Insulin resistance is the underlying metabolic condition; Type 2 diabetes is its advanced stage. In insulin resistance, blood glucose is often still normal — the pancreas is compensating by producing excess insulin. Over time, the pancreas cannot keep up, blood glucose rises, and diabetes develops. Insulin resistance is diagnosable and correctable years before diabetes occurs.

Q: Can I have insulin resistance if my blood sugar is normal?

A: Yes. Standard fasting glucose and HbA1c tests detect diabetes, not insulin resistance. Fasting insulin and HOMA-IR are required to identify insulin resistance at an early stage. Many people with significant insulin resistance have completely normal fasting glucose for years.

Q: Is insulin resistance reversible without medication?

A: In the majority of cases, yes. Whole-food dietary pattern change, structured physical activity, sleep optimisation, and stress physiology work have all demonstrated clinically significant improvements in insulin sensitivity in rigorous randomised controlled trials. Medication is not required to correct insulin resistance — though it may be appropriate alongside lifestyle intervention in some cases, as assessed by the treating physician.

Q: How long does it take to improve insulin resistance?

A: Measurable improvements in fasting insulin and HOMA-IR typically appear within 8–12 weeks of consistent lifestyle intervention. Visceral fat reduction proceeds more slowly, with significant changes typically visible at 3–6 months. The pattern begins shifting earlier than lab values suggest.

Q: Is insulin resistance related to PCOD?

A: In most cases, yes. Insulin resistance is present in approximately 65–80% of women with PCOD, including those at normal body weight. Elevated insulin directly stimulates ovarian androgen production — driving the hormonal pattern of PCOD. Correcting insulin resistance is, in the majority of PCOD cases, the most effective intervention available.

Healthy Regards

Grinto Davy is a metabolic physiotherapist and the founder of ESCASO® Metabolic Clinic. He works with patients on insulin resistance, visceral fat, PCOD, fatty liver, and metabolic recovery using the GDDiET® protocol. escaso.in